Last reviewed · How we verify
Microzide — Competitive Intelligence Brief
marketed
Thiazide Diuretic [EPC]
ACE
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Microzide (hydrochlorothiazide) — Generic (originally Merck). Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Microzide TARGET | hydrochlorothiazide | Generic (originally Merck) | marketed | Thiazide Diuretic [EPC] | ACE | 1959-01-01 |
| Ecclock | SOFPIRONIUM BROMIDE | Kaken Pharmaceutical | marketed | Muscarinic acetylcholine receptor M3 | 2024-01-01 | |
| Talvey | TALQUETAMAB | Janssen Biotech | marketed | T-cell surface glycoprotein CD3 | 2023-01-01 | |
| Epkinly | EPCORITAMAB | Genmab Us, Inc. | marketed | Bispecific CD20-directed CD3 T Cell Engager [EPC] | T-cell surface glycoprotein CD3 | 2023-01-01 |
| Tzield | TEPLIZUMAB | Provention Bio Inc | marketed | CD3-directed Antibody [EPC] | T-cell surface glycoprotein CD3 | 2022-01-01 |
| Candesartan Cilexetil | CILEXETIL | Alembic | marketed | Ace Inhibitor | 2021-01-01 | |
| Mylotarg | GEMTUZUMAB | Wyeth Pharms Inc | marketed | CD33-directed Immunoconjugate [EPC] | Myeloid cell surface antigen CD33 | 2020-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Microzide · 11878022 · Formulation · US
Sponsor landscape (Thiazide Diuretic [EPC] class)
- Cosette · 2 drugs in this class
- Takeda · 2 drugs in this class
- Daiichi Sankyo · 1 drug in this class
- · 1 drug in this class
- Generic (originally Merck) · 1 drug in this class
- Generic (originally Merck/AstraZeneca) · 1 drug in this class
- Roxane Laboratories · 1 drug in this class
- Direct_Rx · 1 drug in this class
- Aarxion Anda Hlding · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Microzide CI watch — RSS
- Microzide CI watch — Atom
- Microzide CI watch — JSON
- Microzide alone — RSS
- Whole Thiazide Diuretic [EPC] class — RSS
Cite this brief
Drug Landscape (2026). Microzide — Competitive Intelligence Brief. https://druglandscape.com/ci/hydrochlorothiazide. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab